申请人:Melior Discovery, Inc.
公开号:US20150231116A1
公开(公告)日:2015-08-20
The present disclosure describes compounds and pharmaceutically acceptable salts thereof and compositions and formulations comprising the same that are useful in methods of treating dyskinesia or related disorders, and methods for treating dyskinesia or related disorders.